Effects of the Dual Endothelin Receptor Antagonist Aprocitentan on Body Weight and Fluid Homeostasis in Healthy Subjects on a High Sodium Diet

Aprocitentan is a novel, oral, dual endothelin receptor antagonist (ERA) in development in difficult‐to‐control hypertension. As fluid retention and edema are concerns with ERAs, we investigated whether aprocitentan causes weight gain in healthy subjects on a high sodium diet and explored potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Gueneau de Mussy, Pierre, Sidharta, Patricia N., Wuerzner, Gregoire, Maillard, Marc P., Guérard, Nicolas, Iglarz, Marc, Flamion, Bruno, Dingemanse, Jasper, Burnier, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984323/
https://www.ncbi.nlm.nih.gov/pubmed/32897570
http://dx.doi.org/10.1002/cpt.2043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984323/
https://www.ncbi.nlm.nih.gov/pubmed/32897570
http://dx.doi.org/10.1002/cpt.2043

Ejemplares similares